RCAT vs CDRE

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 30, 2026

RCAT

57.8
AI Score
VS
RCAT Wins

CDRE

46.1
AI Score

Investment Advisor Scores

RCAT

58score
Recommendation
HOLD

CDRE

46score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric RCAT CDRE Winner
Revenue 35.66M 362.56M CDRE
Net Income -61.81M 13.38M CDRE
Gross Margin 14.7% 40.6% CDRE
Net Margin -173.3% 3.7% CDRE
Operating Income -65.95M 29.95M CDRE
ROE -13.1% 3.9% CDRE
ROA -11.7% 1.5% CDRE
Total Assets 527.49M 917.30M CDRE
Cash 325.55M 53.98M RCAT
Debt/Equity 0.00 1.02 RCAT
Current Ratio 14.86 2.14 RCAT

Relative Price Performance (Last 90 Days)

RCAT 1M: -23.1% · 3M: -36.7% CDRE 1M: -12.6% · 3M: -17.4%

Current Technical Phase

RCAT

Markdown
Sell / avoid

Price below a falling SMA50 (slope -7.9%), weak momentum, RSI 32

RSI (14): 32.3 · Price: $6.40

CDRE

Markdown
Sell / avoid

Price below a falling SMA50 (slope -2.6%), weak momentum, RSI 27

RSI (14): 26.5 · Price: $25.00

Fundamentals Snapshot

Metric RCAT CDRE
Market Cap — —
Forward P/E -21.3 15.2
Trailing P/E — 30.9
Revenue (TTM) — —
Revenue Growth 5.3% 0.3%
Gross Margin 0.1% 0.4%
Operating Margin -1.9% 0.1%
EPS -0.78 0.81
Dividend Yield — 0.02%

Frequently Asked Questions

Based on our detailed analysis, RCAT is currently the stronger investment candidate, winning 3 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.